Literature DB >> 21437372

[Essential drugs and pharmaceutical care: reflection on the access to drugs through lawsuits in Brazil].

João Maurício Brambati Sant'ana1, Vera Lúcia Edais Pepe, Claudia Garcia Serpa Osorio-de-Castro, Miriam Ventura.   

Abstract

The guarantee of pharmaceutical care as a legal right established by the Brazilian federal constitution of 1988 led to an increase in lawsuits to put that right into practice. This phenomenon has been dubbed the judicialization of pharmaceutical care. Studies on this topic have revealed, on the one hand, deficiencies in the access of Unified Health Care (SUS) users to drugs included in Ministry of Health pharmaceutical care lists, and, on the other hand, limitations of the legal system to deal with the situation. The present article addresses these issues in the context of the conceptual framework that supports the Brazilian drug policy and pharmaceutical care policy, especially the notions of essential drugs and allocation of scarce resources.

Mesh:

Substances:

Year:  2011        PMID: 21437372     DOI: 10.1590/s1020-49892011000200010

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  3 in total

1.  Financing of Pharmaceutical Services in the municipal management of the Brazilian Unified Health System.

Authors:  Daniel Resende Faleiros; Francisco de Assis Acurcio; Juliana Álvares; Renata Cristina Rezende Macedo do Nascimento; Ediná Alves Costa; Ione Aquemi Guibu; Orlando Mario Soeiro; Silvana Nair Leite; Margô Gomes de Oliveira Karnikowski; Karen Sarmento Costa; Augusto Afonso Guerra
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

2.  Health and Ethical Consequences of Outsourcing Pivotal Clinical Trials to Latin America: A Cross-Sectional, Descriptive Study.

Authors:  Núria Homedes; Antonio Ugalde
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

Review 3.  Prioritization of strategies to approach the judicialization of health in Latin America and the Caribbean.

Authors:  Carlos Eduardo Pinzón-Flórez; Evelina Chapman; Leonardo Cubillos; Ludovic Reveiz
Journal:  Rev Saude Publica       Date:  2016-09-01       Impact factor: 2.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.